Skip to main content

Medicines' inclisiran expected to outsell bemepedoic acid

Analysts expect The Medicines Company's (Nasdaq: MDCO) inclisiran to outsell Esperion Therapeutics Inc.'s (Nasdaq: ESPR) bemepedoic acid. Shares of The Medicines Company soared $3.98 to close at $28.81 while Esperion stock added 73 cents to close at $77.93.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.